Daniel K. Spiegelman
Sits on 5 boards. Overboarded · 5 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 5 boards, counting each seat separately. Longest: Spruce Biosciences Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Spruce Biosciences Inc. July 22, 202555.2%
-
vTv Therapeutics Inc. June 10, 202599.9%
-
vTv Therapeutics Inc. June 11, 202499.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 29, 2025 | Kyverna Therapeutics Inc. | Grant or award | +16,634 | — | — |
| Jun 4, 2024 | Myriad Genetics Inc. | Open-market sale | −3,788 | $22.05 | $83,525 |
| Jun 3, 2024 | Myriad Genetics Inc. | Open-market sale | −3,788 | $22.04 | $83,488 |
| Jun 2, 2023 | Myriad Genetics Inc. | Open-market sale | −8,638 | $23.01 | $198,760 |
| Jun 1, 2023 | Myriad Genetics Inc. | Grant or award | +15,151 | — | — |
Questions about Daniel K. Spiegelman
What boards is Daniel K. Spiegelman on?
Daniel K. Spiegelman sits on the boards of Kyverna Therapeutics Inc., Maze Therapeutics Inc., Myriad Genetics Inc., Spruce Biosciences Inc. and vTv Therapeutics Inc.
How long has Daniel K. Spiegelman served on boards?
Our records show at least 14 years of board service across 5 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.